News for Avenue Therapeutics, Inc. (49Y.F)

Published at

Mar 2, 2021 6:51 AM

by rttnews.com

mixed

mixed

FDA Says No To ATNX And CRMD, Morphic Jumps On IBD Trial Data, INO's REVEAL 1 Meets Goals

Today's Daily Dose brings you news about the regulatory set back of Athenex's oral Paclitaxel and CorMedix's Defencath, ASLAN Pharma's Atopic Dermatitis trial results, FDA panel review of FibroGen's Roxadustat, Morphic Therapeutic's Phase 1 single ascending dose clinical trial of MORF-057, which is in development for the treatment of inflammatory bowel disease, and STRATA Skin's CEO transition.

SSKN E2OM.SG E2OM.F E2OM.BE TMBR OTRK NNFN.MU NNFN.F MNKD HY1N.MU HY1N.F HY1N.BE HQ8F.F HQ8F.BE GBS FGEN CRMD BPC2.F ATXI APEN 49Y.F 49Y.BE 1FG.F 19KA.SG 19KA.F 19KA.BE ATNX 2MT.F

Read more →
Published at

Feb 27, 2021 5:58 PM

by benzinga.com

mixed

mixed

The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...

SRPT PFED.BA PFE.SG PFE.MX PFE.MU PFE.F PFE.DE PFE.BE PFE MRNA.MX MRNA GIS.MU GIS.F GIS.DE GIS.BE GILD.MX GILD.MI GILD BNTXN.MX BNTX AQST AB3A.SG AB3A.MU AB3A.F AB3A.BE 22UA.MU 22UA.F 22UA.DE 22UA.BE 0QF.SG 0QF.MU 0QF.F 0QF.BE XP0.SG XP0.F XFOR XENE VOR TXMD TTOO TPTX TERN SYRS SYN STIM SNSE SILK SFYC.F SFYC.BE SBBP SANA RIGL RI2A.MU RI2A.F RI2A.BE RGNX RETA RB0.MU RB0.F RB0.BE PHVS PGEN PASG PAND OSUR OPTN OPNT OMER NVV1.MU NVV1.F NVV1.BE NVAX.MX NVAX NRC.SG NRC.MU NRC.F MRK.PA MRK.MX MRK MJC.MU MJC.F MCRB LHDX LABP INO.MX INO INMB I9DN.SG I9DN.MU I9DN.F I9DN.BE I5X.F GLYC GKO.F GKO.BE GBMB.SG GBMB.MU GBMB.F GBMB.BE FOLD.MX FOLD FLGT.MX FLGT FGEN FBIO EYPT EVFM EVAX EP3.SG EP3.F EGRX DMTK.MX DMTK CXS.SG CXS.F CXS.BE CNB.F CNB.BE CLPT CHMA CCXI BOLT BHVN AXSM AVU.F AVU.BE ATXI ATRS ATRA ATNX AT2.F AT2.BE ANIK ANGN AM6.F AM6.BE AKP.F AKP.BE AGRX ADVM ADAG ACOR ABUS 7F0.F 7F0.BE 6MK.MU 6MK.F 6MK.DE 6MK.BE 69BN.SG 69BN.F 49Y.F 49Y.BE 48Q.F 3T2.MU 3T2.F 3T2.BE 3O8.MU 3O8.F 3O8.BE 2R3.F 2OW.MU 2OW.F 2OW.BE 2MT.F 2CX.SG 2CX.MU 2CX.BE 29T.F 29T.BE 1S9.SG 1S9.F 1S9.BE 1FG.F 1E6.SG 1E6.F 1AQ1.MU 1AQ1.F 1AQ1.BE 19X.SG 19X.MU 19X.F 19X.BE 0S9.F 0OP.F 0OP.BE 0AL.F 0AL.BE SPPI NTR.BE

Read more →
Published at

Jan 6, 2021 6:00 PM

by benzinga.com

neutral

neutral

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fortress Biotech, Inc. (FBIO)

LOS ANGELES, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming January 26, 2021 deadline to file a ...

FBIO CNB.F CNB.BE ATXI 49Y.F 49Y.BE

Read more →
Published at

Jan 6, 2021 3:23 PM

by insidermonkey.com

positive

positive

Is Avenue Therapeutics (ATXI) Stock a Buy For 2021?

Clark Street Value sold 2/3rds of its position in Avenue Therapeutics Inc. (NASDAQ:ATXI) stock. Clark Street Value is an individual investor that is focused...

ATXI 49Y.F 49Y.BE

Read more →
Published at

Jan 3, 2021 9:22 AM

by marketscreener.com

neutral

neutral

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline - FBIO

NEW YORK, Jan. 3, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc.?? and certain of its officers.? The class...

FBIO CNB.F CNB.BE ATXI 49Y.F 49Y.BE

Read more →
Published at

Jan 3, 2021 9:21 AM

by prnewswire.com

neutral

neutral

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline - FBIO

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc. ("Fortress" or the "Company") (NASDAQ: FBIO)...

FBIO CNB.F CNB.BE ATXI 49Y.F 49Y.BE

Read more →
Published at

Jan 3, 2021 9:21 AM

by thestreet.com

neutral

neutral

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses On Their Investment In Fortress Biotech, Inc. Of Class Action Lawsuit And Upcoming Deadline - FBIO

NEW YORK, Jan. 3, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc. ("Fortress" or the

FBIO CNB.F CNB.BE ATXI 49Y.F 49Y.BE

Read more →
Published at

Jan 3, 2021 9:21 AM

by markets.businessinsider.com

neutral

neutral

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fortress Biotech, Inc. of Class Action Lawsuit and Upcoming Deadline - FBIO

NEW YORK, Jan. 3, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortress Biotech, Inc. ('Fortre...

FBIO CNB.F CNB.BE ATXI 49Y.F 49Y.BE

Read more →